51
|
Aulinas A, Ramírez MJ, Barahona MJ, Valassi E, Resmini E, Mato E, Santos A, Crespo I, Bell O, Surrallés J, Webb SM. Telomere length analysis in Cushing's syndrome. Eur J Endocrinol 2014; 171:21-9. [PMID: 24743394 DOI: 10.1530/eje-14-0098] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
INTRODUCTION Hypercortisolism in Cushing's syndrome (CS) is associated with increased morbidity and mortality. Hypercortisolism also occurs in chronic depressive disorders and stress, where telomere length (TL) is shorter than in controls. We hypothesized that shortening of telomere might occur in CS and contribute to premature aging and morbidity. AIM To investigate TL in CS patients compared with controls. METHODS Seventy-seven CS patients (14 males, 59 pituitary, 17 adrenal, and one ectopic; 21 with active disease) were compared with 77 gender-, age-, and smoking-matched controls. Fifteen CS were evaluated longitudinally, during active disease and after remission of hypercortisolism. Leukocyte TL was measured by telomere restriction fragment-Southern technique. Clinical markers were included in a multiple linear regression analysis to investigate potential predictors of TL. RESULTS Mean TL in CS patients and controls was similar (7667 vs 7483 bp, NS). After adjustment for age, in the longitudinal evaluation, TL was shorter in active disease than after remission (7273 vs 7870, P<0.05). Age and dyslipidemia were negative predictors (P<0.05), and total leukocyte count was a positive predictor for TL (P<0.05). As expected, a negative correlation was found between TL and age (CS, R=-0.400 and controls, R=-0.292; P<0.05). No correlation was found between circulating cortisol, duration of exposure to hypercortisolism or biochemical cure and TL. CONCLUSION Even though in the cross-sectional comparison of CS and controls no difference in TL was found, in the longitudinal evaluation, patients with active CS had shorter TL than after biochemical cure of hypercortisolism. These preliminary results suggest that hypercortisolism might negatively impact telomere maintenance. Larger studies are needed to confirm these findings.
Collapse
Affiliation(s)
- Anna Aulinas
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - María-José Ramírez
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - María-José Barahona
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Elena Valassi
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Eugenia Resmini
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Eugènia Mato
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Alicia Santos
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Iris Crespo
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Olga Bell
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Jordi Surrallés
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| | - Susan M Webb
- Endocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, SpainEndocrinology/Medicine DepartmentsSant Pau Biomedical Research Institute, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Servei d'Endocrinologia, C/Sant Antoni Maria Claret, 167, 08025 Barcelona, SpainDepartment of Genetics and MicrobiologyCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 745), Universitat Autònoma de Barcelona, Bellaterra, Barcelona, SpainEndocrinology DepartmentHospital Universitari Mutua Terrassa, Terrassa, Barcelona, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER Unit 747)ISCIII, Hospital de Sant Pau, Barcelona, SpainEndocrinology DepartmentCenter for Biomedical Network Research on Bioenginnering, Biomaterials and Nanomedicine (CIBER-BBN), Hospital de Sant Pau, Barcelona, Spain
| |
Collapse
|